Učitavanje...
Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics
Nearly 350 IgG-based therapeutics are approved for clinical use or are under development for many diseases lacking adequate treatment options. These include molecularly engineered biologicals comprising the IgG Fc-domain fused to various effector molecules (so-called Fc-fusion proteins) that confer...
Spremljeno u:
| Izdano u: | Crit Rev Biotechnol |
|---|---|
| Glavni autori: | , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2013
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4876602/ https://ncbi.nlm.nih.gov/pubmed/24156398 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/07388551.2013.834293 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|